Savara News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

05.03.20	Savara to Report Fourth Quarter/Year-End 2019 Financial Results and Provide Business Update (Businesswire)
31.12.19	ARDS Turning Heads, AXSM's Momentum Continues, SVRA Abuzz, Jiankui Jailed (RTTNews)
30.12.19	Savara Granted Breakthrough Therapy Designation for Molgradex for the Treatment of Autoimmune Pulmonary Alveolar Proteinosis (aPAP) (Businesswire)
20.12.19	Savara Announces Private Placement of $26.8 Million, With Total Potential Proceeds of $75.0 Million (Businesswire)
03.12.19	Savara Announces the Appointment of Dr. An van Es-Johansson to Board of Directors (Businesswire)
27.11.19	Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) (Businesswire)
26.11.19	Savara’s COO and CMO to Present at the Evercore ISI 2nd Annual HealthCONx Conference (Businesswire)
18.11.19	Savara Appoints Badrul Chowdhury, M.D., Ph.D as Chief Medical Officer (Businesswire)
12.11.19	Savara to Present at the Stifel 2019 Healthcare Conference (Businesswire)
07.11.19	Savara Reports Third Quarter 2019 Financial Results and Provides Business Update (Businesswire)
31.10.19	Savara to Report Third Quarter 2019 Financial Results and Provide Business Update (Businesswire)
03.10.19	Healthcare Stocks That Plunged To New Lows (SVRA, ONCY, MTFB…) (RTTNews)
02.10.19	Savara Announces FDA Response From Type C Meeting on Molgradex for aPAP Development Program (Businesswire)
25.09.19	5 Top Gainers In Healthcare Sector Today (OVID, ZEAL, VCNX…) (RTTNews)
18.09.19	Savara to Present Comprehensive Data From Pivotal Phase 3 IMPALA Study at 2019 ERS (Businesswire)
13.06.19	Savara Shares Sink 72% After Late-stage Study Fails (RTTNews)
03.06.19	Not For The Faint-hearted Though... (RTTNews)
30.05.18	CODX Explodes, AXON Completes Restructuring, No Time To Frown For EOLS (RTTNews)
25.05.18	Huntington Library's Board of Trustees Honors Mark Twain Scholar (PR Newswire)
12.03.18	SVRA Disappoints, SNY/REGN's Praluent Price To Be Cut, OBSV On Watch (RTTNews)
11.03.18	Savara : Aironite Fails To Meet Primary Endpoint In Indie Phase 2 Study (RTTNews)
11.03.18	An Ear To The Pharma: 4 Stocks To Watch This Week (RTTNews)
04.03.18	An Ear To The Pharma: 7 Stocks To Watch This Week (RTTNews)
22.12.17	Savara Submits IND To FDA For Expansion Of Molgradex Impala Study Into U.S. (RTTNews)
11.07.17	Positive Interim Results Of Aironite Phase 2 Study Presented At 4th Annual Drug Discovery And Development Symposium For Pulmonary Hypertension (PR Newswire)
20.06.17	Savara Set To Join Russell Microcap® Index (PR Newswire)
07.06.17	Savara Announces Closing Of Public Offering Of Common Stock (PR Newswire)
05.06.17	Savara To Present At The Jefferies 2017 Global Healthcare Conference On June 9th (PR Newswire)
02.06.17	Savara Announces Pricing Of Public Offering Of Common Stock (PR Newswire)
10.05.17	Savara Announces Expedited U.S. Molgradex Development Strategy (PR Newswire)
08.05.17	Savara Announces Issuance Of U.S. Composition Of Matter Patent Covering AeroVanc (PR Newswire)
01.05.17	Savara Secures $15 Million Loan And Security Agreement With Silicon Valley Bank (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Savara Inc Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten